Altria Group, Inc. has issued a total of $1 billion in senior unsecured notes, comprising $500 million of 4.500% Notes due 2030 and $500 million of 5.250% Notes due 2035. These notes are guaranteed by Philip Morris USA Inc., a wholly owned subsidiary, and rank equally with the company's existing and future senior unsecured indebtedness. The interest on both series of notes will be paid semiannually, starting February 6, 2026.
The issuance was facilitated through a Terms Agreement with several underwriters, including Barclays Capital Inc. and Citigroup Global Markets Inc. The company has filed a Prospectus and a Prospectus Supplement with the Securities and Exchange Commission in relation to this public offering. The 2030 Notes will mature on August 6, 2030, while the 2035 Notes will mature on August 6, 2035.
linkAug 06, 2025 16:57:40
Altria Group, Inc. announced its financial results for the second quarter and first half of 2025, reporting a net revenue decrease of 1.7% to $6.1 billion in the second quarter, primarily due to lower revenues in the smokeable products segment. The company returned over $4 billion to shareholders through dividends and share repurchases in the first half. Adjusted diluted earnings per share (EPS) increased by 8.3% to $1.44, while reported diluted EPS decreased by 36.2% to $1.41, influenced by prior year gains from the sale of commercialization rights.
For 2025, Altria narrowed its full-year adjusted diluted EPS guidance to a range of $5.35 to $5.45, reflecting a growth rate of 3.0% to 5.0% from a base of $5.19 in 2024. The company noted a decrease in domestic cigarette shipment volumes, which fell by 10.2% in the second quarter and 11.9% in the first half, attributed to industry decline and retail share losses. Conversely, the oral tobacco segment saw a revenue increase driven by higher pricing, with adjusted operating company income rising by 10.9% in the second quarter.
linkJul 30, 2025 07:03:56
Altria Group, Inc. has entered into an Extension Agreement effective July 23, 2025, to amend its $3.0 billion senior unsecured revolving credit agreement. This amendment extends the expiration date from October 24, 2028, to October 24, 2029, while all other terms of the agreement remain unchanged.
The credit agreement involves JPMorgan Chase Bank, N.A. and Citibank, N.A. as administrative agents, with various lenders having established relationships with Altria for financial services. The details of the Extension Agreement are included in the attached exhibit, which provides further context regarding the agreement's terms.
linkJul 23, 2025 16:50:14
Altria Group, Inc. has announced a blackout period for its Deferred Profit-Sharing Plans, which will begin at 4:00 p.m. Eastern Time on July 10, 2025, and is expected to end during the week of July 13, 2025. During this time, participants will have limited access to their accounts and will not be able to direct or diversify investments, nor make loans, withdrawals, or distributions from their accounts. This transition is due to a change in trustee services from State Street Bank and Trust Company to Fidelity Management Trust Company, effective July 11, 2025.
Additionally, during the blackout period, directors and executive officers of Altria will be subject to trading restrictions under the Sarbanes-Oxley Act and Regulation BTR. These restrictions prohibit transactions involving the company's common stock acquired in connection with their roles, encompassing both direct ownership and transactions involving immediate family members or certain entities. Violating these rules may lead to the requirement to disgorge profits and could result in civil and criminal penalties.
linkJun 03, 2025 13:16:11
Altria Group, Inc. has announced its first-quarter results for 2025, reporting net revenues of $5.26 billion, a decrease of 5.7% compared to the same period in 2024. The company noted a significant decline in reported diluted earnings per share (EPS), which fell by 47.9% to $0.63, primarily due to a non-cash impairment charge related to its e-vapor reporting unit goodwill. However, adjusted diluted EPS increased by 6.0% to $1.23, driven by fewer shares outstanding and higher adjusted operating companies income despite lower income from equity investments and net periodic benefit income. Altria also reaffirmed its full-year adjusted diluted EPS growth guidance of 2% to 5% for 2025, projecting a range of $5.30 to $5.45, excluding certain amortization expenses.
In addition to its financial performance, Altria highlighted its ongoing commitment to shareholder returns, having repurchased 5.7 million shares in the first quarter at a total cost of $326 million. The company also paid dividends totaling $1.7 billion. Notably, Altria's NJOY products experienced mixed results, with a significant increase in consumables shipment volume but a sharp decline in device shipments. The company is actively managing the impact of recent regulatory changes, including an importation ban affecting NJOY ACE, which has led to strategic adjustments in its operations.
linkApr 29, 2025 07:03:23
Altria Group, Inc. reported a net earnings increase to $11.26 billion for the year ending December 31, 2024, up from $8.13 billion in 2023. The company's revenues were $24.02 billion, reflecting a relatively stable performance despite a slight decline compared to the previous year. Additionally, the company announced a dividend of $4.00 per share, indicating its commitment to returning value to shareholders. However, total liabilities increased to $37.37 billion, compared to $42.06 billion in 2023, suggesting a shift in financial obligations that may warrant further analysis.
On the negative side, Altria's total assets decreased from $38.57 billion in 2023 to $35.18 billion in 2024, primarily driven by a reduction in cash and cash equivalents. The company also faced significant challenges with its investments in equity securities, reporting losses of $652 million, which contrasts sharply with the previous year's gains. Furthermore, the accumulated other comprehensive losses improved slightly, but the overall stockholders’ equity remained in a deficit position of $2.19 billion, indicating ongoing financial pressures.
linkJan 30, 2025 07:23:23
Altria Group, Inc. announced its 2024 financial results, reporting net revenues of $24 billion, which saw a slight decrease of 1.9% compared to the previous year. The company highlighted a reported diluted earnings per share (EPS) of $6.54, reflecting a significant increase of 43.1%. The growth in EPS was primarily attributed to favorable income tax items and fewer shares outstanding. Additionally, Altria completed a $3.4 billion share repurchase program and announced a new $1 billion program to continue returning cash to shareholders.
On the downside, Altria faced challenges in its smokeable products segment, leading to a decline in overall revenues. The company reported a decrease in net revenues from smokeable products, which was partially offset by gains in oral tobacco products. Moreover, the U.S. International Trade Commission's decision regarding NJOY could impact future operations, as it may lead to restrictions on certain product sales. The competitive landscape for e-vapor products remains difficult, with illicit products gaining market share, complicating Altria's ability to meet its long-term growth targets.
linkJan 30, 2025 07:03:37
Altria Group, Inc. reported net revenues of $6.3 billion for the third quarter of 2024, a slight decrease of 0.4% compared to the previous year, primarily due to declines in the smokeable products segment. However, the company experienced a notable increase in reported diluted earnings per share (EPS), which rose by 9.8% to $1.34, driven by a reduction in shares outstanding and higher operating income. The oral tobacco products segment showed resilience, contributing positively to overall profitability, and the company continued its commitment to shareholders through dividends and share repurchases.
On the downside, Altria faced a decrease in net revenues for the first nine months of 2024, down 2.5% to $18 billion, largely attributed to lower revenues in the smokeable products segment. The company also reported challenges with domestic cigarette shipment volumes, which fell by 8.6% in the third quarter, reflecting ongoing pressures from the illicit e-vapor market and changing consumer preferences. Additionally, while the company announced a new initiative aimed at modernizing operations, it also anticipates significant pre-tax charges related to this initiative, which could impact future financial results.
linkOct 31, 2024 07:03:01
Altria's second-quarter results show strong growth in innovative smoke-free products, with NJOY gaining FDA approval for menthol e-vapor products. However, overall revenues declined by 4.6%, and adjusted earnings per share dropped by 1.6%. The company returned over $5.8 billion to shareholders through buybacks and dividends. They narrowed their full-year earnings guidance to $5.07-$5.15 per share, indicating modest growth expectations. Despite challenges, Altria remains focused on transitioning smokers to smoke-free options.
linkJul 31, 2024 07:02:01
Altria Group reports a decline in Q1 revenues, but reaffirms confidence in full-year earnings. The company highlights progress in traditional tobacco businesses, success with NJOY, and a significant partial sale of its investment in ABI. Altria emphasizes commitment to shareholder returns through an expanded share repurchase program. The company's R&D focus has shifted towards new product platforms. Altria's corporate responsibility areas include sustainability and transparency. The 2024 full-year guidance anticipates growth, though external factors pose uncertainties.
linkApr 25, 2024 07:03:15